Abstract
Single-cell RNA sequencing (scRNA-seq) has transformed gene expression analysis by revealing cellular heterogeneity that is obscured in bulk tissue measurements. This is particularly relevant to lung adenocarcinoma (LUAD), where malignant, immune, stromal, and endothelial cells interact within a complex tumor microenvironment. However, the high dimensionality, sparsity, sequencing variability, and batch effects of scRNA-seq data present substantial challenges for reliable biological interpretation. This review examines computational and machine-learning approaches across the scRNA-seq analysis workflow, encompassing quality control, normalization, feature selection, dimensionality reduction, clustering, and cell annotation. Conventional methods, including k-means, hierarchical, and graph-based clustering, are considered alongside advanced approaches such as autoencoders, variational autoencoders, and graph neural networks. Their applications in downstream analyses, including differential expression, pathway enrichment, trajectory inference, and cell-cell communication, are discussed within a LUAD-focused context. The review further evaluates how analytical assumptions, model interpretability, and validation practices influence biological conclusions. Emerging developments in spatial transcriptomics, multimodal integration, and explainable machine learning are also highlighted. The key contribution is an integrated, validation-oriented framework connecting computational outputs with biological interpretation and evidence-supported claims, moving beyond a descriptive catalogue of methods. This perspective emphasizes rigorous method selection and independent validation to strengthen insights into cellular heterogeneity and LUAD biology.

This publication has 24 references indexed in Scilit: